| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 81.82% | Piper Sandler | → $2 | Reiterates | Neutral → Neutral |
| 05/11/2023 | 445.45% | Oppenheimer | → $6 | Reiterates | Outperform → Outperform |
| 05/11/2023 | 27.27% | Morgan Stanley | $2.5 → $1.4 | Maintains | Equal-Weight |
| 05/11/2023 | 81.82% | Piper Sandler | → $2 | Reiterates | → Neutral |
| 03/28/2023 | 81.82% | Piper Sandler | $2.25 → $2 | Maintains | Neutral |
| 03/24/2023 | 81.82% | Baird | $3 → $2 | Maintains | Outperform |
| 11/09/2022 | 127.27% | Morgan Stanley | $5 → $2.5 | Maintains | Equal-Weight |
| 11/09/2022 | 104.55% | Piper Sandler | $4.5 → $2.25 | Maintains | Neutral |
| 11/02/2022 | 172.73% | WestPark Capital | → $3 | Initiates Coverage On | → Hold |
| 08/04/2022 | 309.09% | Piper Sandler | $3 → $4.5 | Maintains | Neutral |
| 07/18/2022 | 172.73% | Piper Sandler | $5 → $3 | Downgrades | Overweight → Neutral |
| 05/05/2022 | 354.55% | Piper Sandler | $6 → $5 | Maintains | Overweight |
| 04/14/2022 | 445.45% | Credit Suisse | → $6 | Initiates Coverage On | → Outperform |
| 02/24/2022 | 354.55% | Morgan Stanley | $11 → $5 | Maintains | Equal-Weight |
| 02/24/2022 | 445.45% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 01/13/2022 | 809.09% | Piper Sandler | $12 → $10 | Maintains | Overweight |
| 07/19/2021 | 900% | Morgan Stanley | → $11 | Initiates Coverage On | → Equal-Weight |
| 07/07/2021 | 1536.36% | New Street Research | → $18 | Initiates Coverage On | → Buy |
| 05/14/2021 | 1354.55% | Piper Sandler | $22 → $16 | Maintains | Overweight |
| 04/01/2021 | 1718.18% | Baird | → $20 | Initiates Coverage On | → Outperform |
| 03/19/2021 | 1718.18% | Oppenheimer | → $20 | Initiates Coverage On | → Outperform |
| 03/18/2021 | 1718.18% | Oppenheimer | → $20 | Initiates Coverage On | → Outperform |
| 03/18/2021 | 1900% | Piper Sandler | → $22 | Initiates Coverage On | → Overweight |
| 03/17/2021 | 2172.73% | Craig-Hallum | → $25 | Initiates Coverage On | → Buy |
| 03/17/2021 | 2627.27% | Roth Capital | → $30 | Initiates Coverage On | → Buy |
What is the target price for Aeva Technologies (AEVA)?
The latest price target for Aeva Technologies (NYSE: AEVA) was reported by Piper Sandler on August 9, 2023. The analyst firm set a price target for $2.00 expecting AEVA to rise to within 12 months (a possible 81.82% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aeva Technologies (AEVA)?
The latest analyst rating for Aeva Technologies (NYSE: AEVA) was provided by Piper Sandler, and Aeva Technologies reiterated their neutral rating.
When is the next analyst rating going to be posted or updated for Aeva Technologies (AEVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aeva Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aeva Technologies was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating Aeva Technologies (AEVA) correct?
While ratings are subjective and will change, the latest Aeva Technologies (AEVA) rating was a reiterated with a price target of $0.00 to $2.00. The current price Aeva Technologies (AEVA) is trading at is $1.10, which is within the analyst's predicted range.